author/year | types of surgery | Time of block | No. | type of block and local anaesthetic | assessment of sensory Block | intraoperative analgesia | Postoperative analgesia | Complications |
---|---|---|---|---|---|---|---|---|
Aksu 2019 [16] | MRM; mastectomy+SLNB; Lumpectomy+ ALND | Before induction of GA | 25 | ESPB group: 0.25% bupivacaine 20 ml (10 ml for each level) at bi-level (T2-T4) | N | fentanyl 2 mg/kg, tramadol, paracetamol | morphine PCA | Not reported |
25 | GA group: Received no intervention | |||||||
Elsabeeny 2020 [17] | MRM | After induction of GA | 25 | ESPB group: 0.25% bupivacaine 25 mL at the T5 vertebral level | N | intravenous morphine 0.1 mg/kg. | Ketorolac morphine prn | Not reported |
25 | GA group: Received no intervention | |||||||
Gürkan 2018 [18] | MRM; mastectomy+SLNB; Lumpectomy+ ALND | Before induction of GA | 25 | ESPB group: 0.25% bupivacaine 20 ml at the T4 vertebral level | N | fentanyl 2 mg/kg, tramadol, paracetamol | morphine PCA | Not reported |
25 | GA group: Received no intervention | |||||||
Gürkan 2020 [19] | MRM;Breast conserving surgery mastectomy | Before induction of GA | 25 | ESPB group: 0.25% bupivacaine 20 ml at T4 vertebral level. | N | fentanyl 2 mg/kg, tramadol, paracetamol | morphine PCA paracetamol 1 mg for every 6 h | Not reported |
25 | GA group: Received no intervention | |||||||
He 2020 [20] | MRM ± ALND | Before induction of GA | 20 | ESPB group: 0.5%ropivacaine 20 ml at the vertebral T3 level | N | N/S | Flurbiprofen axetil prn | Not reported |
20 | GA group: Received no intervention | |||||||
Li 2020 [21] | MRM | Before induction of GA | 30 | ESPB group: 0.25% bupivacaine 30 ml at T3-T5 vertebral level. | N | fentanyl | morphine PCA | Not reported |
30 | GA group: Received no intervention | |||||||
Seelam 2020 [22] | MRM | Before induction of GA | 50 | ESPB group: 0.25% bupivacaine 30 ml T4 transverse process | N | fentanyl 1.5μg/kg | Morphine prn paracetamol 1 g TID | Not reported |
50 | GA group: Received no intervention | |||||||
Sharma 2020 [23] | total mastectomy + ALND | Before induction of GA | 30 | ESPB group: 0.5%ropivacaine 20 ml, 0.4 mL/kg the T5 level | Y | fentanyl 1μg/kg, diclofenac 1.5 mg/kg | morphine PCA paracetamol 1 g TID | Not reported |
30 | GA group: Received no intervention | |||||||
Singh 2019 [24] | MRM | Before induction of GA | 20 | ESPB group: 0.5% bupivacaine 20 ml at the T5 vertebral level | Y | morphine 0.1 mg/kg | morphine PCA, diclofenac 1.5 mg/kg TID | Not reported |
20 | GA group: Received no intervention | |||||||
Wang 2019 [25] | radical mastectomy | Before induction of GA | 50 | ESPB group: 0.375%ropivacaine 20 ml at the T5 spinous process | Y | sufentanil 0.4 μg/kg | Sufentanil PCA, Flurbiprofen axetil prn | skin itch |
50 | GA group: Received no intervention | |||||||
Yao 2019 [26] | MRM | Before induction of GA | 39 | ESPB group: 0.5%ropivacaine 25 ml at the T4 spinous process | N | Sufentanil 0.5 μg/kg | Sufentanil PCA flurbiprofen axetil 50 mg TID | Not reported |
40 | GA group: 0.9% physiological saline 25 ml |